What is a common treatment for bipolar disorder?

Carbamazepine is commonly used as a treatment for bipolar disorder, particularly for patients who experience rapid cycling or are refractory to traditional mood stabilizers such as lithium. It is an anticonvulsant medication that has mood-stabilizing properties, making it effective for managing the manic and depressive episodes associated with bipolar disorder.

Lithium remains a first-line treatment for the management of bipolar disorder, but in cases where lithium is ineffective or poorly tolerated, carbamazepine may be used as an alternative mood stabilizer. Additionally, it helps to enhance mood stability and reduce the frequency and intensity of mood episodes.

In contrast, SSRIs, stimulants, and MAO inhibitors are not primary treatments for bipolar disorder. SSRIs can potentially worsen mania if used alone in patients with bipolar disorder, while stimulants may increase the risk of manic episodes. MAO inhibitors, although they can be effective for depression, are not typically used in bipolar disorder due to their potential for triggering manic episodes and dietary restrictions associated with their use. Thus, carbamazepine is an appropriate and common choice for treating this condition.